George Scangos
2021
In 2021, George Scangos earned a total compensation of $20.7M as President and Chief Executive Officer at Vir Biotechnology, a 1,979% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $487,000 |
|---|---|
| Option Awards | $12,129,858 |
| Salary | $575,000 |
| Stock Awards | $7,479,180 |
| Other | $11,600 |
| Total | $20,682,838 |
Scangos received $12.1M in option awards, accounting for 59% of the total pay in 2021.
Scangos also received $487K in non-equity incentive plan, $575K in salary, $7.5M in stock awards and $11.6K in other compensation.
Rankings
In 2021, George Scangos' compensation ranked 305th out of 12,405 executives tracked by ExecPay. In other words, Scangos earned more than 97.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 305 out of 12,405 | 98th |
Division Manufacturing | 91 out of 5,494 | 98th |
Major group Chemicals And Allied Products | 27 out of 2,369 | 99th |
Industry group Drugs | 23 out of 2,090 | 99th |
Industry Biological Products, Except Diagnostic Substances | 11 out of 452 | 98th |
Source: SEC filing on April 7, 2022.
Scangos' colleagues
We found four more compensation records of executives who worked with George Scangos at Vir Biotechnology in 2021.